Autism Spectrum Disorder with Comorbid Anxiety and Sleep Disturbance
A 7-year-old girl with a diagnosis of autism spectrum disorder (ASD) and average intellectual ability is brought by her parents for follow-up. She attends a mainstream classroom with an aide. Over the past 6 months, she has developed increasing anxiety, especially around changes in routine, and has frequent meltdowns at school. She also has difficulty falling asleep, taking 1-2 hours each night, and wakes up 2-3 times. Her parents are exhausted. She has no seizures. Examination is unremarkable except for mild hypotonia and poor eye contact. The parents ask about medication for sleep and anxiety. They are hesitant about using medications and prefer non-pharmacological approaches first.
1. What is the first-line non-pharmacological approach for this child's sleep problems, and what is the evidence base?
Read the worked answer
The first-line approach is behavioral sleep intervention, specifically parent-implemented behavioral strategies such as establishing a consistent bedtime routine, setting limits, and using graduated extinction (e.g., checking in at increasing intervals). For children with ASD, visual supports (e.g., picture schedules) and social stories can enhance understanding. The evidence base includes randomized controlled trials and meta-analyses showing that behavioral interventions improve sleep onset latency and night wakings in children with ASD, with moderate effect sizes. Melatonin is often used as an adjunct but is not first-line. Given the parents' preference, starting with behavioral strategies is appropriate, with close follow-up to monitor progress.
2. If behavioral strategies are insufficient and medication is considered for sleep, what would you recommend and why?
Read the worked answer
Melatonin is the most evidence-supported medication for sleep in ASD. It is recommended at a dose of 1-3 mg, given 30-60 minutes before bedtime, with slow titration to a maximum of 6 mg. It has a favorable safety profile and is supported by randomized controlled trials (e.g., the SON-RISE study) showing improvements in sleep onset and duration. Risperidone may improve sleep as a side effect but is not first-line for sleep alone due to metabolic and extrapyramidal risks. Clonidine and guanfacine are sometimes used but have less evidence. Melatonin should be combined with ongoing behavioral strategies. Parents should be counseled about possible side effects (headache, enuresis, morning grogginess) and the importance of good sleep hygiene.
3. For the anxiety and meltdowns, what psychological intervention is most appropriate, and what accommodations might be considered at school?
Read the worked answer
Cognitive behavioral therapy (CBT) adapted for ASD is the most appropriate psychological intervention for anxiety in verbal children with ASD. It includes affective education, cognitive restructuring, exposure, and parent involvement. School accommodations may include a sensory-friendly environment, visual schedules, advanced warning of transitions, access to a calm-down space, and social skills support. A functional behavioral assessment (FBA) can identify triggers and inform a behavior intervention plan (BIP). If anxiety remains impairing, SSRIs (e.g., sertraline, fluoxetine) may be considered, but with caution due to potential behavioral activation and the need for monitoring. The approach should be multimodal, involving the family, school, and clinicians.